# A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

> clinical trial · VERIFIED · 2026-06-25

Status: RECRUITING · Sponsor: Amicus Therapeutics · Condition: Fabry Disease

- Company: Amicus Therapeutics
- Sector: rare-disease
- Primary source: https://clinicaltrials.gov/study/NCT06904261

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.